NOT KNOWN DETAILS ABOUT LINK ALTERNATIF MBL77

Not all sufferers with CLL require therapy. Despite all recent developments, the iwCLL nevertheless recommends watchful observation for sufferers with asymptomatic illness.86 This suggestion relies on at the very least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FC